| Dr Garth W Lecheminant, MD | |
|
2490 S Woodworth Loop Ste 450, Palmer, AK 99645-7407 | |
| (907) 745-9401 | |
| Not Available |
| Full Name | Dr Garth W Lecheminant |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 31 Years |
| Location | 2490 S Woodworth Loop Ste 450, Palmer, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023076007 | NPI | - | NPPES |
| MD5147 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 5147 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mat-su Surgical Associates Apc | 6901804046 | 4 |
News Archive
Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended that the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout.
Limiting gatherings to fewer than 10 people and closing educational institutions were among the most effective nonpharmaceutical interventions at reducing transmission of SARS-CoV-2, a new modeling study finds.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.
› Verified 9 days ago
| Entity Name | Mat-su Surgical Associates Apc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396849428 PECOS PAC ID: 6901804046 Enrollment ID: O20061127000398 |
News Archive
Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended that the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout.
Limiting gatherings to fewer than 10 people and closing educational institutions were among the most effective nonpharmaceutical interventions at reducing transmission of SARS-CoV-2, a new modeling study finds.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Garth W Lecheminant, MD Po Box 876774, Wasilla, AK 99687-6774 Ph: (907) 745-8100 | Dr Garth W Lecheminant, MD 2490 S Woodworth Loop Ste 450, Palmer, AK 99645-7407 Ph: (907) 745-9401 |
News Archive
Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended that the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout.
Limiting gatherings to fewer than 10 people and closing educational institutions were among the most effective nonpharmaceutical interventions at reducing transmission of SARS-CoV-2, a new modeling study finds.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the Company's dermaPACE device will be the subject of a presentation at Plastic Surgery 2011, the American Society of Plastic Surgeons' National Meeting being held September 23-27 in Denver.
DxNA, a molecular diagnostics company headquartered in St. George, Utah, announced today that the DxNA GeneSTAT PCR system has successfully completed evaluation studies under the direction of a California laboratory supported by the Joint FAO/IAEA Programme in Food and Agriculture.
› Verified 9 days ago
Tak Ming Ko, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2480 S Woodworth Loop Ste 180, Palmer, AK 99645 Phone: 907-373-8281 Fax: 855-212-0736 | |
Dr. Shannon Gulley, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 425 E Dahlia Ave Ste J, Palmer, AK 99645 Phone: 907-746-1520 Fax: 907-746-1521 | |
Mr. Michael R Senta, M.D., FACS Surgery Medicare: Not Enrolled in Medicare Practice Location: 2490 S Woodworth Loop, Suite 450, Palmer, AK 99645 Phone: 907-745-8100 Fax: 907-746-2655 | |
John Zwiacher, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2490 S Woodworth Loop, Suite 300, Palmer, AK 99645 Phone: 907-357-1917 | |
David John Morrow, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2490 S Woodworth Loop Ste 450, Palmer, AK 99645 Phone: 907-745-8100 Fax: 907-746-2655 | |
Dr. Brent Taylor, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2490 S Woodworth Loop Ste 400, Palmer, AK 99645 Phone: 907-745-9400 Fax: 907-745-9444 |